Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuj Gupta

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Biorxiv : the Preprint Server for Biology|October 31, 2023
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Iscience|September 7, 2023
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cellsAlok K Singh, Rulin Wang, Kara A Lombardo, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
Nature Communications|August 28, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
JCI Insight|April 22, 2026
Somatic mutations reveal hyperactive Notch signaling in prurigo nodularisAhmad Rajeh, Shahin Shahsavari, Hannah Cornman, et al.
The Journal of Clinical Investigation|October 4, 2022
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYCLaura A Sena, Rajendra Kumar, David E Sanin, et al.
Cancer Immunology Research|February 24, 2022
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor MicroenvironmentDimitrios N Sidiropoulos, Christine I Rafie, Julie K Jang, et al.
Journal of the American College of Cardiology|June 16, 2026
10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk PatientsTamim M Nazif, Matheus Simonato, Raj R Makkar, et al.
JCO Global Oncology|June 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|October 31, 2023
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
Iscience|September 7, 2023
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cellsAlok K Singh, Rulin Wang, Kara A Lombardo, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
Nature Communications|August 28, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.
JCI Insight|April 22, 2026
Somatic mutations reveal hyperactive Notch signaling in prurigo nodularisAhmad Rajeh, Shahin Shahsavari, Hannah Cornman, et al.
The Journal of Clinical Investigation|October 4, 2022
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYCLaura A Sena, Rajendra Kumar, David E Sanin, et al.
Cancer Immunology Research|February 24, 2022
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor MicroenvironmentDimitrios N Sidiropoulos, Christine I Rafie, Julie K Jang, et al.
Journal of the American College of Cardiology|June 16, 2026
10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk PatientsTamim M Nazif, Matheus Simonato, Raj R Makkar, et al.
JCO Global Oncology|June 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.
Pageof 20